Medicare-backed breast cancer screenings skyrocket, but do patients benefit?

Medicalxpress: July 1, 2014

Breast cancer screening costs for Medicare patients skyrocketed between 2001 and 2009, but the increase did not lead to earlier detection of new breast cancer cases, according to a study published by Yale School of Medicine researchers in the July 1Journal of the National Cancer Institute. While the number of performed among Medicare patients remained stable during the same time period, the study focused on the adoption of newer imaging technologies in the Medicare population, such as . Brigid Killelea, M.D., assistant professor of surgery, and Cary Gross, M.D., professor of internal medicine at Yale School of Medicine and director of the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale Cancer Center, were lead authors of the study. Read More